SHARE THIS VIDEO —
Moderna announces positive results from kids trial, plans to submit to FDA
This version of Mmvo124555845833 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
Moderna announced positive data from their Covid-19 study for kids from ages six to eleven, the results from the trial showing the vaccine generated a strong immune response.
Stay informed with daily digest and insights from NBC News Clone. We repackage top headlines for our global readers.
